Evidence map›Paper›PMID 9174127›Full record

ArticleClinical & experimental metastasis1997

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

M E Miele, A De La Rosa, J H Lee, D J Hicks, J U Dennis, P S Steeg, D R Welch

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Metastasis suppressors: functional pathways.Laboratory investigation; a journal of technical methods and pathology · 2018
    Review
  3. Metastasis suppressor genes.Histology and histopathology · 2013
    Review
  4. Genomics screens for metastasis genes.Cancer metastasis reviews · 2012
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Translational approaches using metastasis suppressor genes.Journal of bioenergetics and biomembranes · 2006
    Review
  10. Article
  11. Article
  12. Article
  13. Basic and translational advances in cancer metastasis: Nm23.Journal of bioenergetics and biomembranes · 2003
    Review
  14. Review
  15. Review
  16. Article
  17. Nm23/nucleoside diphosphate kinase in human cancers.Journal of bioenergetics and biomembranes · 2000
    Review
  18. Article
  19. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  20. The role of metastasis suppressor genes in metastatic dormancy.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M E MieleThe Jake Gittlen Cancer Research Institute, Department of Experimental Pathology, The Pennsylvania State University College of Medicine, Hershey 17033-0850, USA.
A De La Rosa
J H Lee
D J Hicks
J U Dennis
P S Steeg
D R Welch
Pennsylvania State University · USNational Cancer Institute · US

Funding

METASTASIS SUPPRESSOR GENES IN HUMAN CUTANEOUS MELANOMAR01CA062168 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WELCH, DANNY R · 1994 to 1999
–
NCI NIH HHS CA62168
6 · The paper itself

Abstract

Metastasis is suppressed more than 95% following microcell-mediated transfer of a single copy of neomycin-tagged human chromosome 6 (neo6) into the human melanoma cell lines C8161 and MelJuSo. Concomitant with metastasis suppression is upregulation of NME1 (Nm23-H1) mRNA and protein expression. The purposes of this study were to determine whether NME1 expression was responsible for metastasis suppression in neo6/melanoma hybrids, and whether genes on chromosome 6 regulate NME1. Using neo6/C8161 cells, transfection of CAT reporter constructs linked to the NME1 promoter failed to consistently induce CAT. Therefore, it does not appear that genes on chromosome 6 directly control transcription of NME1. Transfection and overexpression of NME1 in MelJuSo, under the control of the CMV promoter, resulted in 40-80% inhibition of lung metastasis following i.v. inoculation of 2 x 10(5) cells. Only one transfectant of C8161 subclone 9 (C8161cl.9) cells was suppressed for metastasis. Control transfections with pCMVneo or pSV2neo did not suppress metastasis in either cell line. Taken together, these data suggest that NME1 can reduce metastatic potential of some human melanoma cells; but, this inhibitory activity appears to be independent of the metastasis suppression following introduction of chromosome 6 into C8161 and MelJuSo human melanoma cell lines.

Indexed as

Chromosomes, Human, Pair 6Monomeric GTP-Binding ProteinsNucleoside-Diphosphate KinaseAnimalsGenes, Tumor SuppressorHumansMelanomaMiceNM23 Nucleoside Diphosphate KinasesTranscription FactorsTransfectionTumor Cells, CulturedMonomeric GTP-Binding ProteinsNM23 Nucleoside Diphosphate KinasesNME1 protein, humanNme1 protein, mouseNucleoside-Diphosphate KinaseTranscription Factors

Identifiers

PMID9174127
OpenAlexW194764232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.